EcoDrugPlus

Ptk2 Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSMSIG00000018459
Gene Symbol: PTK2B
1 Cross references
284 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6

Ensembl ID : ENSMSIG00000013435
Gene Symbol: PTK6
1 Cross references
185 Possible Orthologues:

Rho-Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSMSIG00000022459
Gene Symbol: ROCK1
1 Cross references
230 Possible Orthologues:

Rho-Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSMSIG00000011916
Gene Symbol: ROCK2
1 Cross references
319 Possible Orthologues:

Ros1 Proto-Oncogene

Ensembl ID : ENSMSIG00000022755
Gene Symbol: ROS1
1 Cross references
139 Possible Orthologues:

Rous Sarcoma Oncogene

Ensembl ID : ENSMSIG00000027828
Gene Symbol: SRC
1 Cross references
277 Possible Orthologues:

Sem1, 26s Proteasome Complex Subunit

Ensembl ID : ENSMSIG00000007847
Gene Symbol: SEM1
1 Cross references
170 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSMSIG00000002054
Gene Symbol: TEK
1 Cross references
179 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSMSIG00000020879
Gene Symbol: TTK
1 Cross references
218 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSMSIG00000020305
Gene Symbol: UGCG
1 Cross references
226 Possible Orthologues:

Wee 1 Homolog 1 (S. Pombe)

Ensembl ID : ENSMSIG00000027935
Gene Symbol: WEE1
1 Cross references
241 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSMSIG00000021303
Gene Symbol: YES1
1 Cross references
278 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).